Review





Similar Products

96
MedChemExpress hdac inhibitor entinostat
Frozen skin biopsies from healthy donors were cultured ex vivo and stimulated with IFN-γ, followed by IFN-γ removal and treatment with histone-modifying enzyme inhibitors during the resolution period. Keratinocytes were subsequently isolated and subjected to bulk RNA-seq. (a) Experimental design for investigating the effects of histone-modifying enzyme inhibitors on transcriptional resolution after IFN-γ removal in keratinocytes. (b) Flow cytometric analysis of H3K27ac and H3K27me3 levels in keratinocytes isolated from frozen skin biopsies treated with <t>entinostat</t> or tazemetostat as indicated. (c) Volcano plots of differentially expressed genes in keratinocytes isolated at day 10 from frozen skin biopsies treated with entinostat (top) or tazemetostat (bottom). The left and middle panels compare inhibitor-treated samples with DMSO-treated samples under unstimulated (left) and IFN-γ removal (middle) conditions, respectively. The right panels compare the inhibitor effect relative to DMSO between IFN-γ removal and unstimulated conditions. Blue and orange dots indicate genes significantly downregulated and upregulated, respectively, whereas gray dots indicate non-significant genes in each indicated comparison. Dotted lines indicate the threshold for differential expression (|log2 fold change| > 1, FDR < 0.05). Up to eight significant genes with the lowest FDR are labeled. (d) Hallmark IFN-γ response ssGSEA scores in keratinocytes isolated from frozen skin biopsies treated with entinostat (left) or tazemetostat (right) under the indicated conditions. RNA-seq analyses in (c,d) used samples from n = 3 independent donors per condition. Each symbol represents an individual donor.
Hdac Inhibitor Entinostat, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hdacs/Entinostat/bio_rxiv__64898__2026__10__30__763216-48-4-7
Average 96 stars, based on 1 article reviews
hdac inhibitor entinostat - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

94
BPS Bioscience hdac assay developer
Frozen skin biopsies from healthy donors were cultured ex vivo and stimulated with IFN-γ, followed by IFN-γ removal and treatment with histone-modifying enzyme inhibitors during the resolution period. Keratinocytes were subsequently isolated and subjected to bulk RNA-seq. (a) Experimental design for investigating the effects of histone-modifying enzyme inhibitors on transcriptional resolution after IFN-γ removal in keratinocytes. (b) Flow cytometric analysis of H3K27ac and H3K27me3 levels in keratinocytes isolated from frozen skin biopsies treated with <t>entinostat</t> or tazemetostat as indicated. (c) Volcano plots of differentially expressed genes in keratinocytes isolated at day 10 from frozen skin biopsies treated with entinostat (top) or tazemetostat (bottom). The left and middle panels compare inhibitor-treated samples with DMSO-treated samples under unstimulated (left) and IFN-γ removal (middle) conditions, respectively. The right panels compare the inhibitor effect relative to DMSO between IFN-γ removal and unstimulated conditions. Blue and orange dots indicate genes significantly downregulated and upregulated, respectively, whereas gray dots indicate non-significant genes in each indicated comparison. Dotted lines indicate the threshold for differential expression (|log2 fold change| > 1, FDR < 0.05). Up to eight significant genes with the lowest FDR are labeled. (d) Hallmark IFN-γ response ssGSEA scores in keratinocytes isolated from frozen skin biopsies treated with entinostat (left) or tazemetostat (right) under the indicated conditions. RNA-seq analyses in (c,d) used samples from n = 3 independent donors per condition. Each symbol represents an individual donor.
Hdac Assay Developer, supplied by BPS Bioscience, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hdacs/HDAC10%2C+FLAG-tag+Recombinant/pm42966048-514-13-16
Average 94 stars, based on 1 article reviews
hdac assay developer - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
BPS Bioscience fluorogenic hdac substrate class iia
Frozen skin biopsies from healthy donors were cultured ex vivo and stimulated with IFN-γ, followed by IFN-γ removal and treatment with histone-modifying enzyme inhibitors during the resolution period. Keratinocytes were subsequently isolated and subjected to bulk RNA-seq. (a) Experimental design for investigating the effects of histone-modifying enzyme inhibitors on transcriptional resolution after IFN-γ removal in keratinocytes. (b) Flow cytometric analysis of H3K27ac and H3K27me3 levels in keratinocytes isolated from frozen skin biopsies treated with <t>entinostat</t> or tazemetostat as indicated. (c) Volcano plots of differentially expressed genes in keratinocytes isolated at day 10 from frozen skin biopsies treated with entinostat (top) or tazemetostat (bottom). The left and middle panels compare inhibitor-treated samples with DMSO-treated samples under unstimulated (left) and IFN-γ removal (middle) conditions, respectively. The right panels compare the inhibitor effect relative to DMSO between IFN-γ removal and unstimulated conditions. Blue and orange dots indicate genes significantly downregulated and upregulated, respectively, whereas gray dots indicate non-significant genes in each indicated comparison. Dotted lines indicate the threshold for differential expression (|log2 fold change| > 1, FDR < 0.05). Up to eight significant genes with the lowest FDR are labeled. (d) Hallmark IFN-γ response ssGSEA scores in keratinocytes isolated from frozen skin biopsies treated with entinostat (left) or tazemetostat (right) under the indicated conditions. RNA-seq analyses in (c,d) used samples from n = 3 independent donors per condition. Each symbol represents an individual donor.
Fluorogenic Hdac Substrate Class Iia, supplied by BPS Bioscience, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hdacs/Fluorogenic+HDAC+class+2a+substrate/pm42966048-513-28-33
Average 94 stars, based on 1 article reviews
fluorogenic hdac substrate class iia - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
BPS Bioscience fluorogenic acetylated hdac substrate 3
Frozen skin biopsies from healthy donors were cultured ex vivo and stimulated with IFN-γ, followed by IFN-γ removal and treatment with histone-modifying enzyme inhibitors during the resolution period. Keratinocytes were subsequently isolated and subjected to bulk RNA-seq. (a) Experimental design for investigating the effects of histone-modifying enzyme inhibitors on transcriptional resolution after IFN-γ removal in keratinocytes. (b) Flow cytometric analysis of H3K27ac and H3K27me3 levels in keratinocytes isolated from frozen skin biopsies treated with <t>entinostat</t> or tazemetostat as indicated. (c) Volcano plots of differentially expressed genes in keratinocytes isolated at day 10 from frozen skin biopsies treated with entinostat (top) or tazemetostat (bottom). The left and middle panels compare inhibitor-treated samples with DMSO-treated samples under unstimulated (left) and IFN-γ removal (middle) conditions, respectively. The right panels compare the inhibitor effect relative to DMSO between IFN-γ removal and unstimulated conditions. Blue and orange dots indicate genes significantly downregulated and upregulated, respectively, whereas gray dots indicate non-significant genes in each indicated comparison. Dotted lines indicate the threshold for differential expression (|log2 fold change| > 1, FDR < 0.05). Up to eight significant genes with the lowest FDR are labeled. (d) Hallmark IFN-γ response ssGSEA scores in keratinocytes isolated from frozen skin biopsies treated with entinostat (left) or tazemetostat (right) under the indicated conditions. RNA-seq analyses in (c,d) used samples from n = 3 independent donors per condition. Each symbol represents an individual donor.
Fluorogenic Acetylated Hdac Substrate 3, supplied by BPS Bioscience, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hdacs/Fluorogenic+HDAC+substrate+3/pm42966048-513-11-16
Average 94 stars, based on 1 article reviews
fluorogenic acetylated hdac substrate 3 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

96
Selleck Chemicals hdac inhibitor vorinostat
Frozen skin biopsies from healthy donors were cultured ex vivo and stimulated with IFN-γ, followed by IFN-γ removal and treatment with histone-modifying enzyme inhibitors during the resolution period. Keratinocytes were subsequently isolated and subjected to bulk RNA-seq. (a) Experimental design for investigating the effects of histone-modifying enzyme inhibitors on transcriptional resolution after IFN-γ removal in keratinocytes. (b) Flow cytometric analysis of H3K27ac and H3K27me3 levels in keratinocytes isolated from frozen skin biopsies treated with <t>entinostat</t> or tazemetostat as indicated. (c) Volcano plots of differentially expressed genes in keratinocytes isolated at day 10 from frozen skin biopsies treated with entinostat (top) or tazemetostat (bottom). The left and middle panels compare inhibitor-treated samples with DMSO-treated samples under unstimulated (left) and IFN-γ removal (middle) conditions, respectively. The right panels compare the inhibitor effect relative to DMSO between IFN-γ removal and unstimulated conditions. Blue and orange dots indicate genes significantly downregulated and upregulated, respectively, whereas gray dots indicate non-significant genes in each indicated comparison. Dotted lines indicate the threshold for differential expression (|log2 fold change| > 1, FDR < 0.05). Up to eight significant genes with the lowest FDR are labeled. (d) Hallmark IFN-γ response ssGSEA scores in keratinocytes isolated from frozen skin biopsies treated with entinostat (left) or tazemetostat (right) under the indicated conditions. RNA-seq analyses in (c,d) used samples from n = 3 independent donors per condition. Each symbol represents an individual donor.
Hdac Inhibitor Vorinostat, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hdacs/Vorinostat/pm42886545-178-19-23
Average 96 stars, based on 1 article reviews
hdac inhibitor vorinostat - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

97
MedChemExpress hdac inhibition
Frozen skin biopsies from healthy donors were cultured ex vivo and stimulated with IFN-γ, followed by IFN-γ removal and treatment with histone-modifying enzyme inhibitors during the resolution period. Keratinocytes were subsequently isolated and subjected to bulk RNA-seq. (a) Experimental design for investigating the effects of histone-modifying enzyme inhibitors on transcriptional resolution after IFN-γ removal in keratinocytes. (b) Flow cytometric analysis of H3K27ac and H3K27me3 levels in keratinocytes isolated from frozen skin biopsies treated with <t>entinostat</t> or tazemetostat as indicated. (c) Volcano plots of differentially expressed genes in keratinocytes isolated at day 10 from frozen skin biopsies treated with entinostat (top) or tazemetostat (bottom). The left and middle panels compare inhibitor-treated samples with DMSO-treated samples under unstimulated (left) and IFN-γ removal (middle) conditions, respectively. The right panels compare the inhibitor effect relative to DMSO between IFN-γ removal and unstimulated conditions. Blue and orange dots indicate genes significantly downregulated and upregulated, respectively, whereas gray dots indicate non-significant genes in each indicated comparison. Dotted lines indicate the threshold for differential expression (|log2 fold change| > 1, FDR < 0.05). Up to eight significant genes with the lowest FDR are labeled. (d) Hallmark IFN-γ response ssGSEA scores in keratinocytes isolated from frozen skin biopsies treated with entinostat (left) or tazemetostat (right) under the indicated conditions. RNA-seq analyses in (c,d) used samples from n = 3 independent donors per condition. Each symbol represents an individual donor.
Hdac Inhibition, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hdacs/Trichostatin+A/pm42571846-140-0-9
Average 97 stars, based on 1 article reviews
hdac inhibition - by Bioz Stars, 2026-11
97/100 stars
  Buy from Supplier

96
MedChemExpress hdac inhibitor entinostat ms 275
(A) Dose-response curves for ATRT cell lines treated with corin for 72 h (n=3). (B) Relative cell viability of ATRT cell lines treated with corin versus the HDAC inhibitor, entinostat/ MS-275 (n=3). (C) Table showing comparative IC 50 s of corin and entinostat in ATRT cell lines sorted by molecular subtype. IC 50 was calculated based on the total viable cell count relative to DMSO in ATRT cell lines. (D) BrdU immunostaining and quantification of ATRT cells treated with DMSO or corin (n=5). Scale 50 μm. (E) Cleaved caspase 3 (CC3) immunostaining for apoptosis and quantification of ATRT cells treated with DMSO versus corin (n=5). Scale 50 μm. (F) MUSE Annexin V/ 7-AAD assay of ATRT cells treated with DMSO or corin (n=3). (G) Quantification of Annexin V apoptosis assay for corin treatment of ATRT cells in (F). Data is presented as fold change of the total number of ATRT cells undergoing apoptosis following corin treatment relative to DMSO. (H) Western blot of cPARP expression in ATRT cells following 72 h treatment with DMSO versus corin (n=3). The band density normalized to beta actin and relative to DMSO is shown below each band. Statistical Analysis: unpaired, two-tailed student’s t test. All data represents mean ± SD. ** p ≤ 0.01; *** p ≤ 0.001.
Hdac Inhibitor Entinostat Ms 275, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hdacs/Entinostat/pmc13615391-55-1-13
Average 96 stars, based on 1 article reviews
hdac inhibitor entinostat ms 275 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

93
BPS Bioscience fluorogenic hdac assay kits
(A) Dose-response curves for ATRT cell lines treated with corin for 72 h (n=3). (B) Relative cell viability of ATRT cell lines treated with corin versus the HDAC inhibitor, entinostat/ MS-275 (n=3). (C) Table showing comparative IC 50 s of corin and entinostat in ATRT cell lines sorted by molecular subtype. IC 50 was calculated based on the total viable cell count relative to DMSO in ATRT cell lines. (D) BrdU immunostaining and quantification of ATRT cells treated with DMSO or corin (n=5). Scale 50 μm. (E) Cleaved caspase 3 (CC3) immunostaining for apoptosis and quantification of ATRT cells treated with DMSO versus corin (n=5). Scale 50 μm. (F) MUSE Annexin V/ 7-AAD assay of ATRT cells treated with DMSO or corin (n=3). (G) Quantification of Annexin V apoptosis assay for corin treatment of ATRT cells in (F). Data is presented as fold change of the total number of ATRT cells undergoing apoptosis following corin treatment relative to DMSO. (H) Western blot of cPARP expression in ATRT cells following 72 h treatment with DMSO versus corin (n=3). The band density normalized to beta actin and relative to DMSO is shown below each band. Statistical Analysis: unpaired, two-tailed student’s t test. All data represents mean ± SD. ** p ≤ 0.01; *** p ≤ 0.001.
Fluorogenic Hdac Assay Kits, supplied by BPS Bioscience, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hdacs/HDAC1+Fluorogenic+Assay+Kit/10__1016_slash_j__molstruc__2026__147113-137-16-22
Average 93 stars, based on 1 article reviews
fluorogenic hdac assay kits - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

95
TargetMol hdac inhibitor
(A) Dose-response curves for ATRT cell lines treated with corin for 72 h (n=3). (B) Relative cell viability of ATRT cell lines treated with corin versus the HDAC inhibitor, entinostat/ MS-275 (n=3). (C) Table showing comparative IC 50 s of corin and entinostat in ATRT cell lines sorted by molecular subtype. IC 50 was calculated based on the total viable cell count relative to DMSO in ATRT cell lines. (D) BrdU immunostaining and quantification of ATRT cells treated with DMSO or corin (n=5). Scale 50 μm. (E) Cleaved caspase 3 (CC3) immunostaining for apoptosis and quantification of ATRT cells treated with DMSO versus corin (n=5). Scale 50 μm. (F) MUSE Annexin V/ 7-AAD assay of ATRT cells treated with DMSO or corin (n=3). (G) Quantification of Annexin V apoptosis assay for corin treatment of ATRT cells in (F). Data is presented as fold change of the total number of ATRT cells undergoing apoptosis following corin treatment relative to DMSO. (H) Western blot of cPARP expression in ATRT cells following 72 h treatment with DMSO versus corin (n=3). The band density normalized to beta actin and relative to DMSO is shown below each band. Statistical Analysis: unpaired, two-tailed student’s t test. All data represents mean ± SD. ** p ≤ 0.01; *** p ≤ 0.001.
Hdac Inhibitor, supplied by TargetMol, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hdacs/Trichostatin+A/pmc13283986-71-91-96
Average 95 stars, based on 1 article reviews
hdac inhibitor - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

86
Sanofi class i hdac inhibitor hdaci valproate
A Glucose metabolism. Studied metabolic pathways are in bold. B Box plots of standardized expression sum (SES), by RNA-seq, of genes within metabolic pathways in CD4 + cells of RA ( n = 11), healthy controls (HC, n = 57), and of CD4 + cells split by mean expression of BIRC5 gene in high (B5 hi ) and low (B5 lo ) ( n = 24). Boxes indicate IQR and whiskers indicate the minimum and maximum values. GO-terms used for pathway annotation: Glycolysis (GO:0006096); oxidative phosphorylation (OxPhos, GO:0006119 and GO:0022900); pentose phosphate pathway (PPP, GO:0006098); tricarboxylic acid cycle (TCA, GO:0006099). P -values are calculated by Wilcoxon unpaired test. C Heatmap of Spearman’s correlation between HAT, <t>HDAC</t> and metabolic pathways as above. GO-terms used for annotation HAT (GO:0000123) and HDAC (GO:0000118). Asterisks indicate p -values. * < 0.05, ** < 0.01, *** <0.001. D Heatmap of Spearman’s correlation between HAT and HDAC and insulin signaling (IS). Asterisks indicate p -values * < 0.05, ** < 0.01, *** <0.001. E Scatter plot of Spearman’s correlation between plasma insulin levels and SES of insulin signaling. F Uniform manifold approximation and projection (UMAP) map of scaled expression intensity of BIRC5 , IFNG , and TNF in T cells of RA synovial tissue (ST), by single cell transcriptome. BIRC5 Hi CD4 + clusters are indicated. G Heatmap of scaled expression intensity of metabolic pathway (annotated as above) in peripheral blood (PB), synovial fluid (SF), and ST of RA patients, by scRNA-seq. H Violin plot of insulin signaling by SES of INSR, IRS1, IRS2 and IGF1R genes in BIRC5 Hi CD4 + clusters. P-value was calculated by chi-square test. I Violin plot of metabolic pathways SES in cells with high and low IS in BIRC5 Hi CD4 + clusters. P -values are calculated by Wilcoxon unpaired test. Asterisks indicate * < 0.05, ** < 0.01, *** <0.001, **** <0.0001 J . Box plot of BIRC5, IFNG , and TNF expression in Tph cells with high and low IS. Boxes indicate IQR and whiskers indicate the minimum and maximum values. P -values are calculated by Wilcoxon unpaired test. K Heatmap of expression for IL7R-signaling targets in Tph cells high and low IS. Genes regulated by survivin-H3K27ac are in bold. P -values are calculated by Wilcoxon unpaired test. Asterisks indicate * < 0.05, ** < 0.01, *** <0.001, **** <0.0001.
Class I Hdac Inhibitor Hdaci Valproate, supplied by Sanofi, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hdacs/hdac+hdaci+inhibitor+valproate/pmc13201554-277-40-52
Average 86 stars, based on 1 article reviews
class i hdac inhibitor hdaci valproate - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

Image Search Results


Frozen skin biopsies from healthy donors were cultured ex vivo and stimulated with IFN-γ, followed by IFN-γ removal and treatment with histone-modifying enzyme inhibitors during the resolution period. Keratinocytes were subsequently isolated and subjected to bulk RNA-seq. (a) Experimental design for investigating the effects of histone-modifying enzyme inhibitors on transcriptional resolution after IFN-γ removal in keratinocytes. (b) Flow cytometric analysis of H3K27ac and H3K27me3 levels in keratinocytes isolated from frozen skin biopsies treated with entinostat or tazemetostat as indicated. (c) Volcano plots of differentially expressed genes in keratinocytes isolated at day 10 from frozen skin biopsies treated with entinostat (top) or tazemetostat (bottom). The left and middle panels compare inhibitor-treated samples with DMSO-treated samples under unstimulated (left) and IFN-γ removal (middle) conditions, respectively. The right panels compare the inhibitor effect relative to DMSO between IFN-γ removal and unstimulated conditions. Blue and orange dots indicate genes significantly downregulated and upregulated, respectively, whereas gray dots indicate non-significant genes in each indicated comparison. Dotted lines indicate the threshold for differential expression (|log2 fold change| > 1, FDR < 0.05). Up to eight significant genes with the lowest FDR are labeled. (d) Hallmark IFN-γ response ssGSEA scores in keratinocytes isolated from frozen skin biopsies treated with entinostat (left) or tazemetostat (right) under the indicated conditions. RNA-seq analyses in (c,d) used samples from n = 3 independent donors per condition. Each symbol represents an individual donor.

Journal: bioRxiv

Article Title: Establishing an ex vivo platform for molecular profiling of skin structural cells using frozen human skin biopsies

doi: 10.64898/2026.10.30.763216

Figure Lengend Snippet: Frozen skin biopsies from healthy donors were cultured ex vivo and stimulated with IFN-γ, followed by IFN-γ removal and treatment with histone-modifying enzyme inhibitors during the resolution period. Keratinocytes were subsequently isolated and subjected to bulk RNA-seq. (a) Experimental design for investigating the effects of histone-modifying enzyme inhibitors on transcriptional resolution after IFN-γ removal in keratinocytes. (b) Flow cytometric analysis of H3K27ac and H3K27me3 levels in keratinocytes isolated from frozen skin biopsies treated with entinostat or tazemetostat as indicated. (c) Volcano plots of differentially expressed genes in keratinocytes isolated at day 10 from frozen skin biopsies treated with entinostat (top) or tazemetostat (bottom). The left and middle panels compare inhibitor-treated samples with DMSO-treated samples under unstimulated (left) and IFN-γ removal (middle) conditions, respectively. The right panels compare the inhibitor effect relative to DMSO between IFN-γ removal and unstimulated conditions. Blue and orange dots indicate genes significantly downregulated and upregulated, respectively, whereas gray dots indicate non-significant genes in each indicated comparison. Dotted lines indicate the threshold for differential expression (|log2 fold change| > 1, FDR < 0.05). Up to eight significant genes with the lowest FDR are labeled. (d) Hallmark IFN-γ response ssGSEA scores in keratinocytes isolated from frozen skin biopsies treated with entinostat (left) or tazemetostat (right) under the indicated conditions. RNA-seq analyses in (c,d) used samples from n = 3 independent donors per condition. Each symbol represents an individual donor.

Article Snippet: Immediately after transfer, the HDAC inhibitor entinostat (MedChemExpress) (1 μM) or the EZH2 inhibitor tazemetostat (MedChemExpress) (0.1 μM) or DMSO as a vehicle control was added to the medium in the lower chamber.

Techniques: Cell Culture, Ex Vivo, Isolation, RNA Sequencing, Analysis, Comparison, Quantitative Proteomics, Labeling

(A) Dose-response curves for ATRT cell lines treated with corin for 72 h (n=3). (B) Relative cell viability of ATRT cell lines treated with corin versus the HDAC inhibitor, entinostat/ MS-275 (n=3). (C) Table showing comparative IC 50 s of corin and entinostat in ATRT cell lines sorted by molecular subtype. IC 50 was calculated based on the total viable cell count relative to DMSO in ATRT cell lines. (D) BrdU immunostaining and quantification of ATRT cells treated with DMSO or corin (n=5). Scale 50 μm. (E) Cleaved caspase 3 (CC3) immunostaining for apoptosis and quantification of ATRT cells treated with DMSO versus corin (n=5). Scale 50 μm. (F) MUSE Annexin V/ 7-AAD assay of ATRT cells treated with DMSO or corin (n=3). (G) Quantification of Annexin V apoptosis assay for corin treatment of ATRT cells in (F). Data is presented as fold change of the total number of ATRT cells undergoing apoptosis following corin treatment relative to DMSO. (H) Western blot of cPARP expression in ATRT cells following 72 h treatment with DMSO versus corin (n=3). The band density normalized to beta actin and relative to DMSO is shown below each band. Statistical Analysis: unpaired, two-tailed student’s t test. All data represents mean ± SD. ** p ≤ 0.01; *** p ≤ 0.001.

Journal: Neuro-oncology

Article Title: The CoREST complex inhibitor, corin, decreases tumor growth, increases cellular differentiation and extends lifespan in ATRT xenograft models

doi: 10.1093/neuonc/noag160

Figure Lengend Snippet: (A) Dose-response curves for ATRT cell lines treated with corin for 72 h (n=3). (B) Relative cell viability of ATRT cell lines treated with corin versus the HDAC inhibitor, entinostat/ MS-275 (n=3). (C) Table showing comparative IC 50 s of corin and entinostat in ATRT cell lines sorted by molecular subtype. IC 50 was calculated based on the total viable cell count relative to DMSO in ATRT cell lines. (D) BrdU immunostaining and quantification of ATRT cells treated with DMSO or corin (n=5). Scale 50 μm. (E) Cleaved caspase 3 (CC3) immunostaining for apoptosis and quantification of ATRT cells treated with DMSO versus corin (n=5). Scale 50 μm. (F) MUSE Annexin V/ 7-AAD assay of ATRT cells treated with DMSO or corin (n=3). (G) Quantification of Annexin V apoptosis assay for corin treatment of ATRT cells in (F). Data is presented as fold change of the total number of ATRT cells undergoing apoptosis following corin treatment relative to DMSO. (H) Western blot of cPARP expression in ATRT cells following 72 h treatment with DMSO versus corin (n=3). The band density normalized to beta actin and relative to DMSO is shown below each band. Statistical Analysis: unpaired, two-tailed student’s t test. All data represents mean ± SD. ** p ≤ 0.01; *** p ≤ 0.001.

Article Snippet: The HDAC inhibitor entinostat/MS-275 (Cat# HY-12163) and corin (Cat# HY-111048) were purchased from MedChemExpress (NJ, USA).

Techniques: In Vitro, Cell Characterization, Immunostaining, Apoptosis Assay, Western Blot, Expressing, Analysis, Two Tailed Test

A Glucose metabolism. Studied metabolic pathways are in bold. B Box plots of standardized expression sum (SES), by RNA-seq, of genes within metabolic pathways in CD4 + cells of RA ( n = 11), healthy controls (HC, n = 57), and of CD4 + cells split by mean expression of BIRC5 gene in high (B5 hi ) and low (B5 lo ) ( n = 24). Boxes indicate IQR and whiskers indicate the minimum and maximum values. GO-terms used for pathway annotation: Glycolysis (GO:0006096); oxidative phosphorylation (OxPhos, GO:0006119 and GO:0022900); pentose phosphate pathway (PPP, GO:0006098); tricarboxylic acid cycle (TCA, GO:0006099). P -values are calculated by Wilcoxon unpaired test. C Heatmap of Spearman’s correlation between HAT, HDAC and metabolic pathways as above. GO-terms used for annotation HAT (GO:0000123) and HDAC (GO:0000118). Asterisks indicate p -values. * < 0.05, ** < 0.01, *** <0.001. D Heatmap of Spearman’s correlation between HAT and HDAC and insulin signaling (IS). Asterisks indicate p -values * < 0.05, ** < 0.01, *** <0.001. E Scatter plot of Spearman’s correlation between plasma insulin levels and SES of insulin signaling. F Uniform manifold approximation and projection (UMAP) map of scaled expression intensity of BIRC5 , IFNG , and TNF in T cells of RA synovial tissue (ST), by single cell transcriptome. BIRC5 Hi CD4 + clusters are indicated. G Heatmap of scaled expression intensity of metabolic pathway (annotated as above) in peripheral blood (PB), synovial fluid (SF), and ST of RA patients, by scRNA-seq. H Violin plot of insulin signaling by SES of INSR, IRS1, IRS2 and IGF1R genes in BIRC5 Hi CD4 + clusters. P-value was calculated by chi-square test. I Violin plot of metabolic pathways SES in cells with high and low IS in BIRC5 Hi CD4 + clusters. P -values are calculated by Wilcoxon unpaired test. Asterisks indicate * < 0.05, ** < 0.01, *** <0.001, **** <0.0001 J . Box plot of BIRC5, IFNG , and TNF expression in Tph cells with high and low IS. Boxes indicate IQR and whiskers indicate the minimum and maximum values. P -values are calculated by Wilcoxon unpaired test. K Heatmap of expression for IL7R-signaling targets in Tph cells high and low IS. Genes regulated by survivin-H3K27ac are in bold. P -values are calculated by Wilcoxon unpaired test. Asterisks indicate * < 0.05, ** < 0.01, *** <0.001, **** <0.0001.

Journal: Cell Death & Disease

Article Title: Insulin enables acquisition of the IL7R + memory phenotype in PD1 + T cells in RA tissues

doi: 10.1038/s41419-026-08916-6

Figure Lengend Snippet: A Glucose metabolism. Studied metabolic pathways are in bold. B Box plots of standardized expression sum (SES), by RNA-seq, of genes within metabolic pathways in CD4 + cells of RA ( n = 11), healthy controls (HC, n = 57), and of CD4 + cells split by mean expression of BIRC5 gene in high (B5 hi ) and low (B5 lo ) ( n = 24). Boxes indicate IQR and whiskers indicate the minimum and maximum values. GO-terms used for pathway annotation: Glycolysis (GO:0006096); oxidative phosphorylation (OxPhos, GO:0006119 and GO:0022900); pentose phosphate pathway (PPP, GO:0006098); tricarboxylic acid cycle (TCA, GO:0006099). P -values are calculated by Wilcoxon unpaired test. C Heatmap of Spearman’s correlation between HAT, HDAC and metabolic pathways as above. GO-terms used for annotation HAT (GO:0000123) and HDAC (GO:0000118). Asterisks indicate p -values. * < 0.05, ** < 0.01, *** <0.001. D Heatmap of Spearman’s correlation between HAT and HDAC and insulin signaling (IS). Asterisks indicate p -values * < 0.05, ** < 0.01, *** <0.001. E Scatter plot of Spearman’s correlation between plasma insulin levels and SES of insulin signaling. F Uniform manifold approximation and projection (UMAP) map of scaled expression intensity of BIRC5 , IFNG , and TNF in T cells of RA synovial tissue (ST), by single cell transcriptome. BIRC5 Hi CD4 + clusters are indicated. G Heatmap of scaled expression intensity of metabolic pathway (annotated as above) in peripheral blood (PB), synovial fluid (SF), and ST of RA patients, by scRNA-seq. H Violin plot of insulin signaling by SES of INSR, IRS1, IRS2 and IGF1R genes in BIRC5 Hi CD4 + clusters. P-value was calculated by chi-square test. I Violin plot of metabolic pathways SES in cells with high and low IS in BIRC5 Hi CD4 + clusters. P -values are calculated by Wilcoxon unpaired test. Asterisks indicate * < 0.05, ** < 0.01, *** <0.001, **** <0.0001 J . Box plot of BIRC5, IFNG , and TNF expression in Tph cells with high and low IS. Boxes indicate IQR and whiskers indicate the minimum and maximum values. P -values are calculated by Wilcoxon unpaired test. K Heatmap of expression for IL7R-signaling targets in Tph cells high and low IS. Genes regulated by survivin-H3K27ac are in bold. P -values are calculated by Wilcoxon unpaired test. Asterisks indicate * < 0.05, ** < 0.01, *** <0.001, **** <0.0001.

Article Snippet: Cells were stimulated with concanavalin A (ConA, 0.625 μg/mL, MP Biomedicals), and lipopolysaccharide (LPS, 5 μg/mL, Sigma-Aldrich) for 48 h. For immunophenotyping, the cultures were supplemented with insulin (Humalog 100 U/mL, Eli Lilly, Indianapolis, IN, USA) 25 nM and/or the class I HDAC inhibitor (HDACi) valproate, 50 μg/mL (stock 200 mg/mL, Ergenyl, Sanofi, Paris, France) after 24 h. Supernatants were collected for cytokine measures and cells were analyzed by flow cytometry.

Techniques: Expressing, RNA Sequencing, Phospho-proteomics, Clinical Proteomics, Single Cell

A Confocal microscopy images of THP1 cells stained with antibodies to H3K27ac (red) in nucleus (blue) after stimulation with insulin (top), and HDAC-inhibitor (bottom) for 24 h. Images are acquired with 40× magnification with additional digital magnification 1.5×. B Scatter plot of nuclear H3K27ac staining intensity after stimulation with insulin (top) and HDAC-inhibitor (bottom). P -values are calculated by Wilcoxon unpaired test. Asterisks indicate * < 0.05, ** < 0.01, *** <0.001, **** <0.0001. C Histogram of phosphorylated serine 473 (p)AKT1 mean fluorescence intensity in THP1 cells stimulated with 10 nM insulin, by flow cytometry. D Histogram of H3K27ac mean fluorescence intensity in THP1 cells stimulated with increasing concentrations of insulin for 24 h, by flow cytometry. E Histogram of pAKT1 mean fluorescence intensity in human lymphocytes stimulated with increasing concentrations of insulin for 30 min, by flow cytometry.

Journal: Cell Death & Disease

Article Title: Insulin enables acquisition of the IL7R + memory phenotype in PD1 + T cells in RA tissues

doi: 10.1038/s41419-026-08916-6

Figure Lengend Snippet: A Confocal microscopy images of THP1 cells stained with antibodies to H3K27ac (red) in nucleus (blue) after stimulation with insulin (top), and HDAC-inhibitor (bottom) for 24 h. Images are acquired with 40× magnification with additional digital magnification 1.5×. B Scatter plot of nuclear H3K27ac staining intensity after stimulation with insulin (top) and HDAC-inhibitor (bottom). P -values are calculated by Wilcoxon unpaired test. Asterisks indicate * < 0.05, ** < 0.01, *** <0.001, **** <0.0001. C Histogram of phosphorylated serine 473 (p)AKT1 mean fluorescence intensity in THP1 cells stimulated with 10 nM insulin, by flow cytometry. D Histogram of H3K27ac mean fluorescence intensity in THP1 cells stimulated with increasing concentrations of insulin for 24 h, by flow cytometry. E Histogram of pAKT1 mean fluorescence intensity in human lymphocytes stimulated with increasing concentrations of insulin for 30 min, by flow cytometry.

Article Snippet: Cells were stimulated with concanavalin A (ConA, 0.625 μg/mL, MP Biomedicals), and lipopolysaccharide (LPS, 5 μg/mL, Sigma-Aldrich) for 48 h. For immunophenotyping, the cultures were supplemented with insulin (Humalog 100 U/mL, Eli Lilly, Indianapolis, IN, USA) 25 nM and/or the class I HDAC inhibitor (HDACi) valproate, 50 μg/mL (stock 200 mg/mL, Ergenyl, Sanofi, Paris, France) after 24 h. Supernatants were collected for cytokine measures and cells were analyzed by flow cytometry.

Techniques: Confocal Microscopy, Staining, Fluorescence, Flow Cytometry

A Analysis strategy of survivin and H3K27ac deposition, by ChIP-seq, in cis-regulatory elements ( cis -RE) and connected genes in human CD4 + T cells. B Venn diagram of insulin-responsive (InsResp) genes connected to cis -RE with survivin-H3K27ac co-deposition. Genes are identified by DESeq2 analysis of CD4 + cells transcriptome after a) direct insulin stimulation (InsStim) and b) in regression to corresponding plasma insulin levels, by RNA-seq. C Scatter plot of pathway enrichment of insulin-responsive genes, by GSEA GO-terms. Circle size indicates the number of genes in the pathway, and color intensity indicates p -value. D Venn diagram of insulin-responsive (InsResp) genes connected to cis -RE with H3K27ac deposition. Genes are identified by DESeq2 analysis of CD4 + cells transcriptome after a) direct insulin stimulation (InsStim) and b) HDAC inhibition. E Scatter plot of protein subunits with survivin-H3K27ac in HAT (E1) and HDAC (E3) complexes, annotated by STRING database. Circle size represents number of cis- RE with survivin-H3K27ac connected to the gene. Circle color represents beta-coefficient of expression difference by DESeq2 analysis of CD4 + cell transcriptome in regression to corresponding plasma insulin levels. (E2 and E4) Heatmap of transcription difference, by log2FoldChange (FC), in CD4 + cells in regression to plasma insulin levels (InsReg), and after HDAC inhibitor treatment in vitro. F . Bar plot of percentage of H3K27ac and survivin-H3K27ac connected genes in each metabolic pathway. GO-terms used for pathway annotation as in Fig. . G Scatter plot of expression difference of survivin-H3K27ac connected genes in transcriptome of CD4 + cells in regression to plasma insulin levels and after HDACi treatment, by RNA-seq. Expression difference is calculated by DESeq2 analysis. Colour fill corresponds to metabolic pathway annotation of the gene.

Journal: Cell Death & Disease

Article Title: Insulin enables acquisition of the IL7R + memory phenotype in PD1 + T cells in RA tissues

doi: 10.1038/s41419-026-08916-6

Figure Lengend Snippet: A Analysis strategy of survivin and H3K27ac deposition, by ChIP-seq, in cis-regulatory elements ( cis -RE) and connected genes in human CD4 + T cells. B Venn diagram of insulin-responsive (InsResp) genes connected to cis -RE with survivin-H3K27ac co-deposition. Genes are identified by DESeq2 analysis of CD4 + cells transcriptome after a) direct insulin stimulation (InsStim) and b) in regression to corresponding plasma insulin levels, by RNA-seq. C Scatter plot of pathway enrichment of insulin-responsive genes, by GSEA GO-terms. Circle size indicates the number of genes in the pathway, and color intensity indicates p -value. D Venn diagram of insulin-responsive (InsResp) genes connected to cis -RE with H3K27ac deposition. Genes are identified by DESeq2 analysis of CD4 + cells transcriptome after a) direct insulin stimulation (InsStim) and b) HDAC inhibition. E Scatter plot of protein subunits with survivin-H3K27ac in HAT (E1) and HDAC (E3) complexes, annotated by STRING database. Circle size represents number of cis- RE with survivin-H3K27ac connected to the gene. Circle color represents beta-coefficient of expression difference by DESeq2 analysis of CD4 + cell transcriptome in regression to corresponding plasma insulin levels. (E2 and E4) Heatmap of transcription difference, by log2FoldChange (FC), in CD4 + cells in regression to plasma insulin levels (InsReg), and after HDAC inhibitor treatment in vitro. F . Bar plot of percentage of H3K27ac and survivin-H3K27ac connected genes in each metabolic pathway. GO-terms used for pathway annotation as in Fig. . G Scatter plot of expression difference of survivin-H3K27ac connected genes in transcriptome of CD4 + cells in regression to plasma insulin levels and after HDACi treatment, by RNA-seq. Expression difference is calculated by DESeq2 analysis. Colour fill corresponds to metabolic pathway annotation of the gene.

Article Snippet: Cells were stimulated with concanavalin A (ConA, 0.625 μg/mL, MP Biomedicals), and lipopolysaccharide (LPS, 5 μg/mL, Sigma-Aldrich) for 48 h. For immunophenotyping, the cultures were supplemented with insulin (Humalog 100 U/mL, Eli Lilly, Indianapolis, IN, USA) 25 nM and/or the class I HDAC inhibitor (HDACi) valproate, 50 μg/mL (stock 200 mg/mL, Ergenyl, Sanofi, Paris, France) after 24 h. Supernatants were collected for cytokine measures and cells were analyzed by flow cytometry.

Techniques: ChIP-sequencing, Clinical Proteomics, RNA Sequencing, Inhibition, Expressing, In Vitro

A Transition model of PD1 hi Tph cells to the IL7R + T memory cells, influenced by insulin and HDAC inhibition. B Box plot of protein cytokine levels in supernatants of CD4 + cells ( n = 12) stimulated with insulin (25 nM) and HDACi (50 µg/mL) for 24 h, by ELISA. Boxes indicate IQR and whiskers indicate the minimum and maximum values. P -values are calculated by Wilcoxon Sign rank test. C Gating strategy to CD4 + T cell subset analysis by flow cytometry. D Box plot of PD1 and CD27 expression in CD4 + cells ( n = 8) stimulated by insulin and HDACi, by mean fluorescence intensity (MFI). Boxes indicate IQR and whiskers indicate the minimum and maximum values. P -values are calculated by Wilcoxon Sign rank paired test. E Heatmap of expression difference of IL7R-related signaling molecules in CD4 + cells after in vitro stimulation with insulin (25 nM), HDACi (50 µg/mL), IFNγ (50 ng/ml), and survivin inhibitor YM155 (10 μM), by RNA-seq. Genes connected to cis -RE containing survivin-H3K27ac co-deposition are indicated bold. Asterisks indicate RNA-seq p -values * < 0.05, ** < 0.01, *** <0.001, **** <0.0001. F Heatmap showing expression difference, by log2FC, of cluster markers of Tph cluster after insulin stimulation, HDAC inhibition. In bold are the genes supervised by a cis-RE containing survivin-H3K27ac deposition. P -values are calculated by DESeq2 analysis. Asterisks indicate nominal p -values * < 0.05, ** < 0.01, *** <0.001, **** <0.0001.

Journal: Cell Death & Disease

Article Title: Insulin enables acquisition of the IL7R + memory phenotype in PD1 + T cells in RA tissues

doi: 10.1038/s41419-026-08916-6

Figure Lengend Snippet: A Transition model of PD1 hi Tph cells to the IL7R + T memory cells, influenced by insulin and HDAC inhibition. B Box plot of protein cytokine levels in supernatants of CD4 + cells ( n = 12) stimulated with insulin (25 nM) and HDACi (50 µg/mL) for 24 h, by ELISA. Boxes indicate IQR and whiskers indicate the minimum and maximum values. P -values are calculated by Wilcoxon Sign rank test. C Gating strategy to CD4 + T cell subset analysis by flow cytometry. D Box plot of PD1 and CD27 expression in CD4 + cells ( n = 8) stimulated by insulin and HDACi, by mean fluorescence intensity (MFI). Boxes indicate IQR and whiskers indicate the minimum and maximum values. P -values are calculated by Wilcoxon Sign rank paired test. E Heatmap of expression difference of IL7R-related signaling molecules in CD4 + cells after in vitro stimulation with insulin (25 nM), HDACi (50 µg/mL), IFNγ (50 ng/ml), and survivin inhibitor YM155 (10 μM), by RNA-seq. Genes connected to cis -RE containing survivin-H3K27ac co-deposition are indicated bold. Asterisks indicate RNA-seq p -values * < 0.05, ** < 0.01, *** <0.001, **** <0.0001. F Heatmap showing expression difference, by log2FC, of cluster markers of Tph cluster after insulin stimulation, HDAC inhibition. In bold are the genes supervised by a cis-RE containing survivin-H3K27ac deposition. P -values are calculated by DESeq2 analysis. Asterisks indicate nominal p -values * < 0.05, ** < 0.01, *** <0.001, **** <0.0001.

Article Snippet: Cells were stimulated with concanavalin A (ConA, 0.625 μg/mL, MP Biomedicals), and lipopolysaccharide (LPS, 5 μg/mL, Sigma-Aldrich) for 48 h. For immunophenotyping, the cultures were supplemented with insulin (Humalog 100 U/mL, Eli Lilly, Indianapolis, IN, USA) 25 nM and/or the class I HDAC inhibitor (HDACi) valproate, 50 μg/mL (stock 200 mg/mL, Ergenyl, Sanofi, Paris, France) after 24 h. Supernatants were collected for cytokine measures and cells were analyzed by flow cytometry.

Techniques: Inhibition, Enzyme-linked Immunosorbent Assay, Flow Cytometry, Expressing, Fluorescence, In Vitro, RNA Sequencing